Josh Haydon — investor profile photo

Josh Haydon

Life Science Commercialization | Marketing & Sales Ops

📍 United States🔄 Updated November 2026💼 1 investments📅 1 years investing🗓 Last invested Jun 2025
Operator-angel🌍 United States
1
Total investments
0
Early stage
1
Mid stage
0
Late stage
1y
Years active

Portfolio

1 investments · sorted by recency
All investments
Early stage
Mid stage
Late stage
Investor
Jun 2025
Fore Genomics is building a new foundation for lifelong health by capturing high-quality early-life data and integrating it with genetics. We empower parents with meaningful insights about their childs health. By combining real-world childhood data with genomics, Fore Genomics helps families make better health decisions—starting from the very beginning. Backed by the reliability of CLIA-certified and CAP-approved labs, FORESITE 360 is designed to offer a complete genetic profile of your child, unlocking a lifetime of health insights. FORESITE 360 incorporates ongoing re-analysis of DNA, allowing doctors to take practical steps toward managing any detected medical conditions. Without adding a single item to their to-do list, clinicians can now add value for their patients with leading-edge sequencing, high-quality genetic counseling, and annually updated analysis.
Experience · 2 entries
All (2)
Investments (1)
Founder (1)
2025
Investor
Jun 2025
Fore Genomics is building a new foundation for lifelong health by capturing high-quality early-life data and integrating it with genetics. We empower parents with meaningful insights about their childs health. By combining real-world childhood data with genomics, Fore Genomics helps families make better health decisions—starting from the very beginning. Backed by the reliability of CLIA-certified and CAP-approved labs, FORESITE 360 is designed to offer a complete genetic profile of your child, unlocking a lifetime of health insights. FORESITE 360 incorporates ongoing re-analysis of DNA, allowing doctors to take practical steps toward managing any detected medical conditions. Without adding a single item to their to-do list, clinicians can now add value for their patients with leading-edge sequencing, high-quality genetic counseling, and annually updated analysis.
2024
Owner
Aug 2024
Bridge the Gap Between Technical Excellence and Market Demand You built an incredible product. Now lets make sure the market understands why it matters.
Investor lists
Lists that match Josh's portfolio